-
Study aim
-
Evaluation of therapeutic benefits of levothyroxine on lipid profile of patients with subclinical hypothyroidism
-
Design
-
Clinical trial with control group, with parallel groups, three-sided, randomized, on 60 patients
-
Settings and conduct
-
This study is an interventional study (clinical trial) that is performed on adults aged 18 to 50 years with subclinical hypothyroidism and referred to the endocrine clinic, to confirm the diagnosis of patients, before and after confirmation. Initially, patients are re-evaluated for TSH levels after one week. In this study, which is a three-blind clinical trial study, 60 patients with newly diagnosed subclinical hypothyroidism (not yet treated) are included in the study and matched in two groups in terms of age and sex. Are divided into intervention and control groups.After obtaining informed consent, the researcher completes a basic information questionnaire and patients enter the study. In order to be randomized in this evaluation, the random number table method will be used.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Adults 18 to 50 years with sub clinically confirmed hypothyroidism, consent to participate in the evaluation, no previous treatment with levothyroxine
Exclusion criteria : systemic heart, kidney and liver diseases, use of anti thyroid and lithium drugs, radiation therapy or thyroid surgery, pregnancy and central disorder (pituitary gland)
-
Intervention groups
-
Intervention group 1: They receive levothyroxine and the level of fat profile and thyroid tests are checked after a period of six months.
Intervention group two: receive a placebo and the level of fat profile and thyroid tests are checked after a period of six months.
-
Main outcome variables
-
The primary outcome evaluated in this study is the laboratory status of lipid profiles and thyroid function tests.